Santhera Pharmaceuticals Holding announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management. The team was led by partner Matthias Courvoisier (Capital Markets) and senior associate
Santhera Pharmaceuticals Holding announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management. The team was led by partner Matthias Courvoisier (Capital Markets) and senior associate